PROPHYLACTIC ERGOMETRIN VERSUS OXYTOCIN IN THIRD STAGE

PROPHYLACTIC ERGOMETRINE VERSUS OXYTOCIN FOR WOMEN IN THE THIRD STAGE OF LABOUR: A DOUBLE-BLIND, RANDOMIZED TRIAL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201105000292708

Enrollment

600

Registered

2011-05-02

Start date

2011-06-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth POST PARTUM HAEMORRHAGE

Interventions

ERGOMETRINE GROUP

OXYTOCIN GROUP

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Consenting women Women who had vaginal delivery

Exclusion criteria

Exclusion criteria: Refusal of consent Women that had Caesarean Section Women with Antepartum haemorrhage. Women with Pregnancy induced hypertension, chronic hypertension, eclampsia or cardiac disease in pregnancy. Women with severe anaemia in pregnancy.

Design outcomes

Primary

Measure	Time frame
1. Measured blood loss >500 mls after intervention. 2. Side effects (Headache, vomiting, increased diastolic hypertension) within 30 minutes of intervention.	—

Secondary

Measure	Time frame
1. Blood Transfusion 2. Additional Uterotonic agent after enrolment 3. Manual Removal of Placenta 4. Evacuation of retained products of conception 5. Hysterectomy 6. Maternal Death	—

Countries

Nigeria

Contacts

Public ContactTheresa Okoh

Matron

tessynkemokoh@yahoo.co.uk+2348037250991

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026